Keep up with the latest trends and applications of AI in healthcare from the experts at AllazoHealth. Find best practices, tools, and breakthroughs in using artificial intelligence to drive meaningful engagement and outcomes for patient support programs and pharmaceutical marketing.
In the field of chronic diseases, Type 2 diabetes ranks high when it comes to the challenges of therapy initiation and non-adherence. Diabetes accounts for $24.6 billion in wasteful and avoidable healthcare spending in the…
Read more
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels including emails and SMS text messages. In a trial of…
Read more
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of…
Read more
Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer medications (OAMs). There…
Read more
As the days tick down to the inauguration of President-elect Joseph Biden and Vice President-elect Kamala Harris, what will be the priorities of the new administration when it comes to U.S. healthcare? Let’s take a…
Read more
AllazoHealth’s VP, Business Development Dev Mukherjee recently answered questions about specialty medications and the challenges faced by pharmaceutical companies and specialty drug pharmacies in regards to therapy initiation. What challenges do specialty drug patients experience?…
Read more
How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses…
Read more
2020 was dominated by the COVID-19 pandemic, and it will continue to dominate healthcare conversations this year. Looking back, how did the pandemic affect medication adherence? And what lessons were learned? Patient concerns about ability…
Read more
AllazoHealth’s William Grambley, Chief Operating Officer, and Dr. Linda Schultz, VP, Clinical and Customer Success, address the factors that pharmacies should consider when prioritizing their DIR contracts. Their discussion includes how to evaluate thresholds and…
Read more
AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient…
Read more